Cardiac restoration, commonly known as myocardial recovery, is the intricate process dedicated to revitalizing and optimizing the functionality of the heart muscle. This rejuvenation becomes particularly essential following periods of stress or damage to the heart. The comprehensive approach to myocardial recovery involves a spectrum of interventions and treatments designed to enhance the heart's efficiency in pumping blood. The journey towards myocardial recovery often integrates lifestyle modifications, medication management, and, in certain instances, cutting-edge medical procedures. These strategies collectively work towards not only addressing the root causes of cardiac distress but also bolstering the inherent healing mechanisms of the heart. The significance of myocardial recovery lies in its pivotal role in reinstating optimal cardiac function, thereby contributing to an improvement in overall cardiovascular health.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States